The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan (the “Equity Incentive Plan,” initially adopted

in May 2012 and as most recently amended and restated on June 3, 2026) is a source of equity-based awards permitting the

Company to grant to Carlyle employees, directors and consultants non-qualified options, share appreciation rights, common

shares, restricted stock units and other awards based on the Company’s shares of common stock. A total of 77,800,000 shares of

common stock are authorized for the grant of awards under the Equity Incentive Plan, of which a total of 35,738,646 shares of

A summary of the status of the Company’s unvested equity-based awards as of June 30, 2026 and a summary of changes


Unvested Shares	Performance- Vesting Restricted Stock Units	Weighted- Average Grant Date Fair Value	Restricted Stock Units	Weighted- Average Grant Date Fair Value	Unvested Common Shares	Weighted- Average Grant Date Fair Value
Balance, December 31, 2025	14,214,568	$28.63	11,339,034	$47.36	397,838	$46.04
Granted (1)	68,423	$48.81	6,723,596	$57.43	126,507	$61.32
Vested (2)	5,189,824	$26.17	1,294,483	$47.08	—	$—
Forfeited	—	$—	136,536	$48.75	—	$—
Balance, June 30, 2026	9,093,167	$30.18	16,631,611	$51.44	524,345	$49.73

(1)Includes shares reserved for issuance upon settlement of dividend-equivalent rights carried by certain restricted stock units concurrently

(2)Includes 2,552,050 shares that were retired in connection with the net share settlement of equity-based awards. The Company paid

$143.9 million of taxes related to the net share settlement of equity-based awards during the six months ended June 30, 2026, which is

The Company recorded equity-based compensation expense, net of forfeitures, for restricted stock units of $116.0 million

and $92.9 million for the three months ended June 30, 2026 and 2025, respectively, with $15.5 million and $18.1 million of

corresponding deferred tax benefits, respectively. The Company recorded equity-based compensation expense, net of

forfeitures, for restricted stock units of $235.8 million and $196.4 million for the six months ended June 30, 2026 and 2025,

respectively, with $33.1 million and $36.7 million of corresponding deferred tax benefits, respectively. As of June 30, 2026, the

total unrecognized equity-based compensation expense related to unvested restricted stock units was $658.7 million, which is